首页|肠道菌群在治疗高尿酸血症中的研究进展

肠道菌群在治疗高尿酸血症中的研究进展

扫码查看
肠道微生物群定植于人体肠道,其结构变化或失衡可参与嘌呤代谢、酶的合成及炎症细胞因子的释放,进而引起代谢紊乱,这与高尿酸血症的发生、发展密切相关.将肠道菌群作为探究高尿酸血症发病机制的切入点,已成为新的研究热点.本文就不同类型的肠道菌群在高尿酸血症发病机制中的研究现状与进展进行综述,总结了肠道菌群在直接减少尿酸生成;增加嘌呤代谢;影响氨基酸转运,以及增加尿酸排泄等方面的具体作用机制,以期为未来治疗高尿酸血症提供新思路.
Research progress of intestinal flora in the treatment of hyperuricemia
Intestinal microbiota colonizes the human gut,and its structural changes or imbalances can participate in purine metabolism,enzyme synthesis and the release of inflammatory cytokines,thereby causing metabolic disorders,which is closely related to the occurrence and development of hyperuricemia.Taking intestinal flora as the entry point to explore the pathogenesis of hyperuricemia has become a new research hotspot.This paper reviews the research status and progress of different types of intestinal flora in the pathogenesis of hyperuricemia,and summarizes the specific mechanism of intestinal flora in directly reducing uric acid production,and it can increase purine metabolism and affect amino acid transport and increase uric acid excretion,so as to provide new ideas for the future treatment of hyperuricemia

Intestinal floraHyperuricemiaRegulation mechanismReduced uric acid productionIncreased uric acid excretion

闫敏、牛瑞兵、段宝生

展开 >

内蒙古医科大学鄂尔多斯临床医学院,内蒙古鄂尔多斯 017000

内蒙古自治区鄂尔多斯市中心医院检验科,内蒙古鄂尔多斯 017000

肠道菌群 高尿酸血症 调控机制 减少尿酸生产 增加尿酸排泄

内蒙古自治区自然科学基金

2023QN08035

2024

中国医药导报
中国医学科学院

中国医药导报

CSTPCD
影响因子:1.759
ISSN:1673-7210
年,卷(期):2024.21(12)
  • 31